Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8008

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0615-8008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Atorvastatin Calcium 40mg 8008 Apotex 1)

Chemical structure of atorvastatin calcium, showing its molecular configuration including the calcium ion (Ca2+).*

FDA Label Image

Figure-01 (Atorvastatin Calcium 40mg 8008 Apotex 2)

A cumulative incidence line graph comparing Atorvastatin and Placebo over approximately 3.5 years. The Y-axis shows cumulative incidence percentage, and the X-axis shows time in years. The Atorvastatin group has a lower cumulative incidence compared to Placebo throughout the period, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005 noted on the chart.*

FDA Label Image

Figure-02 (Atorvastatin Calcium 40mg 8008 Apotex 3)

A line graph comparing the cumulative hazard percentage over time between placebo and atorvastatin groups. The x-axis represents years of follow-up up to four years, and the y-axis represents cumulative hazard percentage up to 15%. The graph shows lower cumulative hazard in the atorvastatin group compared to placebo throughout the follow-up period.*

FDA Label Image

Figure-03 (Atorvastatin Calcium 40mg 8008 Apotex 4)

A line graph comparing the percentage of subjects experiencing an event over time between Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time in years until the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) with confidence interval (0.69-0.89) and p-value (0.0002).*

FDA Label Image

Principal Display Panel (Atorvastatin 40mg bingo card label)

Label for Atorvastatin Calcium Tabs USP 40 mg from NCS HealthCare of KY, Inc dba Vangard Labs. The label includes barcodes, lot number 8008, expiration date fields, and dosage instructions to store at controlled room temperature (20°-25°C). It is marked for institutional use only. The packaging shows quantity 30 tablets and states the product is manufactured by Apotex and packaged by Vangard Labs in Glasgow, KY.*

FDA Label Image

Principal Display Panel (Atorvasatin 40mg unit dose labe)

The image shows a sheet of multiple labels for Atorvastatin Calcium Tablets USP 40 mg, each including a barcode, lot number 8008, and expiration date placeholder. The labels indicate packaging by Vangard, Glasgow, KY 42141. The bottom portion contains a larger label with detailed information including quantity 30 tablets, storage instructions, manufacturer Apotex, and repackager Vangard Labs. Product NDC is 0615-8008.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.